|
|
| |
| |
| |
| Upcoming Clinical Trials |
| |
| |
1) A phase I/II study of PHY906 plus irinotecan (CPT-11) in patients with advanced
colorectal cancer – study sites in the US. (forecasted start Q4, 2007). |
| |
| 2) A phase IIb efficacy study of PHY906 plus capecitabine in patients with advanced, unresectable hepatocellular carcinoma – study sites in Taiwan (forecasted start Q4, 2007). |
| |
| 3) A phase I/II study of PHY906 plus gemcitabine in patients with advanced Pancreatic cancer-study sites in the US and Taiwan (forecasted start Q2, 2008). |
| |
| 4) A phase I/II study of PHY906 plus sorafenib in patients with advanced liver cancer - study sites in the US and Taiwan (forecasted start Q3, 2008). |
| |
| If you would like more information regarding any of these trials, either as a potential clinical site or as a patient, please contact us at info@phytoceutica.com. |
| |
| Active |
| |
| An investigator-initiated study of PHY906 plus capecitabine in patients with advanced pancreatic cancer – “A Phase I/II, Multi-Center, Open-Label, Dose-Escalation Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma.”study sites in the US. |
|
